Resources
Materials to support healthcare professionals and patients across the BLENREP treatment journey. Select a tab below to browse resources by audience.
-
BLENREP Product Monograph
Full Canadian Product Monograph (PDF) — indications, dosing, safety, and prescribing information.
-
Dosing & administration guide
Step-by-step reference for BLENREP dose calculation, infusion preparation, and modification.
Coming soon -
Eye care management toolkit (HCP)
Resources to support proactive eye care assessment, monitoring, and dose adjustment for ocular adverse events.
Coming soon -
Patient journey card
Concise overview of the BLENREP combination treatment journey, designed for chair-side conversations.
Coming soon -
DREAMM-7 reprint
Peer-reviewed publication of the DREAMM-7 phase 3 trial of BLENREP + bortezomib + dexamethasone.
Coming soon -
DREAMM-8 reprint
Peer-reviewed publication of the DREAMM-8 phase 3 trial of BLENREP + pomalidomide + dexamethasone.
Coming soon -
Continuing education modules
Accredited learning modules covering BLENREP mechanism, efficacy, safety, and management.
Coming soon
-
Patient brochure
Plain-language overview of BLENREP — what it is, what to expect during treatment, and key safety considerations.
Coming soon -
Eye care guide for patients
Practical guide to managing eye-related side effects, including what to watch for and when to call your care team.
Coming soon -
Caregiver support guide
Tools and tips for family members and caregivers supporting someone receiving BLENREP.
Coming soon -
Find a treatment centre
Directory of Canadian centres administering BLENREP combination therapy.
Coming soon -
Adverse-event reporting
How to report a suspected side effect to GSK Canada — call 1-800-387-7374 or contact your healthcare professional.
Coming soon